Literature DB >> 33007187

Clinical dilemmas in local and regional testis cancer.

Gregory J Nason1, Ricardo A Rendon2, Lori Wood3, Robert A Huddart4, Peter Albers5, Lawrence H Einhorn6, Craig R Nichols7, Christian Kollmannsberger8, Lynn Anson-Cartwright1, Padraig Warde9, Michael A S Jewett1, Peter Chung9, Philippe L Bedard10, Aaron R Hansen10, Robert J Hamilton1.   

Abstract

At the Canadian Testis Cancer Workshop, the multidisciplinary management of testis cancer care was discussed. The two-day workshop involved urologists, medical and radiation oncologists, pathologists, radiologists, physician's assistants, residents, fellows, nurses, patients, and patient advocacy group members.This review summarizes the discussion regarding clinical dilemmas in local and regional testis cancer. We present cases that highlight the need for a coordinated approach to individualize care. Overarching themes include the importance of a multidisciplinary approach to testis cancer, willingness to involve a high-volume experienced center, and given that the oncological outcomes are excellent, a reminder that clinical decisions need to prioritize selecting a strategy with the least treatment-related morbidity when safe.

Entities:  

Year:  2021        PMID： 33007187      PMCID： PMC7769526          DOI： 10.5489/cuaj.6913

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  41 in total

1.  Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Authors:  Chunkit Fung; Howard D Sesso; Annalynn M Williams; Sarah L Kerns; Patrick Monahan; Mohammad Abu Zaid; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair J Beard; Christian K Kollmannsberger; Ryan Cook; Sandra Althouse; Shirin Ardeshir-Rouhani-Fard; Steve E Lipshultz; Lawrence H Einhorn; Sophie D Fossa; Lois B Travis
Journal:  J Clin Oncol       Date:  2017-02-27       Impact factor: 44.544

2.  Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.

Authors:  H Patterson; A R Norman; S S Mitra; J Nicholls; C Fisher; D P Dearnaley; A Horwich; M D Mason; R A Huddart
Journal:  Radiother Oncol       Date:  2001-04       Impact factor: 6.280

3.  Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.

Authors:  Andrew Stephenson; Scott E Eggener; Eric B Bass; David M Chelnick; Siamak Daneshmand; Darren Feldman; Timothy Gilligan; Jose A Karam; Bradley Leibovich; Stanley L Liauw; Timothy A Masterson; Joshua J Meeks; Phillip M Pierorazio; Ritu Sharma; Joel Sheinfeld
Journal:  J Urol       Date:  2019-07-08       Impact factor: 7.450

4.  Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

Authors:  Chunkit Fung; Sophie D Fossa; Michael T Milano; Jan Oldenburg; Lois B Travis
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

5.  Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.

Authors:  Peter Albers; Lothar Weissbach; Susanne Krege; Sabine Kliesch; Michael Hartmann; Axel Heidenreich; Peter Walz; Markus Kuczyk; Rolf Fimmers
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

6.  Stage II testicular seminoma: patterns of recurrence and outcome of treatment.

Authors:  Peter W M Chung; Mary K Gospodarowicz; Tony Panzarella; Michael A S Jewett; Jeremy F G Sturgeon; Betty Tew-George; Andrew J S Bayley; Charles N Catton; Michael F Milosevic; Malcolm Moore; Padraig R Warde
Journal:  Eur Urol       Date:  2004-06       Impact factor: 20.096

7.  Complications of post-chemotherapy retroperitoneal lymph node dissection.

Authors:  J Baniel; R S Foster; R G Rowland; R Bihrle; J P Donohue
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

8.  Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.

Authors:  Xavier Garcia-del-Muro; Pablo Maroto; Josep Gumà; Javier Sastre; Marta López Brea; José A Arranz; Nuria Lainez; Diego Soto de Prado; Jorge Aparicio; José M Piulats; Xavier Pérez; Josep R Germá-Lluch
Journal:  J Clin Oncol       Date:  2008-10-20       Impact factor: 44.544

9.  Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.

Authors:  Stephanie A Howard; Kathryn P Gray; Elizabeth K O'Donnell; Fiona M Fennessy; Clair J Beard; Christopher J Sweeney
Journal:  AJR Am J Roentgenol       Date:  2014-10       Impact factor: 3.959

10.  Non-Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival.

Authors:  Pia Paffenholz; Isabel Maria Heidegger; Kathrin Kuhr; Sven Heiko Loosen; David Pfister; Axel Heidenreich
Journal:  Clin Genitourin Cancer       Date:  2017-09-06       Impact factor: 2.872
View more
  1 in total

Review 1.  Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience.

Authors:  G J Nason; Robert J Hamilton
Journal:  World J Urol       Date:  2022-01-06       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.